Earnings Call · Q1 FY2022·2022-05-18

Q1 22EPS +27.78%·Rev n/aQ4 21EPS +8.70%·Rev n/aQ3 21EPS +54.55%·Rev n/aQ2 21EPS -75.00%·Rev n/a⚠ consensus missing

Entera Bio Ltd. ENTX

Unidentified Company Representative — Unknown

Spiros Jamas — Chief Executive Officer

Miranda Toledano — Chief Business Officer, Chief Financial Officer and Head of Strategy

+4.5%1d on move date+4.6% vs SPY3d+18.0%5d+19.0%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ENTX calls or request research access.

More ENTX calls Browse calls Request research access